Insider filing · EWTX
R Michael Carruthers
Chief Financial Officer
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 28 filings in 24 months
ticker →
R Michael Carruthers sold $3.6M of Edgewise Therapeutics (EWTX)
Executed Sep 20 2024, disclosed Sep 24 2024, 4 days later.
Value, as filed
$3.6M
125,092 sh across 4 lots
Executed
Sep 20 2024
the trade date, as filed
Disclosed
Sep 24 2024
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RCR Michael Carruthers (Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX).
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→